Cargando…
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice
Triple negative breast cancer (TNBC), usually presenting with a very aggressive phenotype, is a heterogeneous entity. We aim to discuss new biomarkers, suitable for prognostic and predictive purposes. We retrospectively collected clinical variables and immunohistochemical characteristics of early TN...
Autores principales: | Losurdo, Agnese, De Sanctis, Rita, Fernandes, Bethania, Torrisi, Rosalba, Masci, Giovanna, Agostinetto, Elisa, Gatzemeier, Wolfgang, Errico, Valentina, Testori, Alberto, Tinterri, Corrado, Roncalli, Massimo, Santoro, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674426/ https://www.ncbi.nlm.nih.gov/pubmed/33208857 http://dx.doi.org/10.1038/s41598-020-77043-9 |
Ejemplares similares
-
Never too old to fight breast cancer: A case report
por: Zuradelli, Monica, et al.
Publicado: (2018) -
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab
por: De Sanctis, Rita, et al.
Publicado: (2021) -
Sticking to the Rules: Outcome and Success Rate of Guideline-Based Diarrhea Management in Metastatic Breast Cancer Patients Treated with Abemaciclib
por: Jacobs, Flavia, et al.
Publicado: (2023) -
Single-cell profiling defines the prognostic benefit of CD39(high) tissue resident memory CD8+ T cells in luminal-like breast cancer
por: Losurdo, Agnese, et al.
Publicado: (2021) -
Author Correction: Single-cell profiling defines the prognostic benefit of CD39(high) tissue resident memory CD8+ T cells in luminal-like breast cancer
por: Losurdo, Agnese, et al.
Publicado: (2021)